Jackson Creek Investment Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History

Jackson Creek Investment Advisors’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-93,652	Closed	-$1.09M	–	326
2021 Q4	$1.09M	Sell	93,652 -6,543	-7%	-$80.3K	0.39%	116
2021 Q3	$1.31M	Buy	100,195 +803	+0.8%	+$10.4K	0.49%	33
2021 Q2	$1.28M	Buy	+99,392	New	+$1.14M	0.48%	40
2021 Q1	–	Sell	-84,376	Closed	-$961K	–	348
2020 Q4	$961K	Sell	84,376 -148	-0.2%	-$1.62K	0.38%	133
2020 Q3	$760K	Buy	+84,524	New	+$840K	0.34%	147

Other funds holding IRWD

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Jackson Creek Investment Advisors's IRWD Position: Q1 2022 in Review

Jackson Creek Investment Advisors sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2022, closing a stake of 93,652 shares — an estimated $1.09M sold.

Jackson Creek Investment Advisors first reported a position in IRWD in Q3 2020 and held it in 5 quarters. The position peaked at $1.31M in Q3 2021. 221 funds tracked by Wall St. Rank hold IRWD as of Q1 2022.

Jackson Creek Investment Advisors reported no remaining Ironwood Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
Jackson Creek Investment Advisors sold 93,652 Ironwood Pharmaceuticals shares in Q1 2022, an estimated $1.09M.
Jackson Creek Investment Advisors first reported a position in Ironwood Pharmaceuticals in Q3 2020 and held it in 5 quarters.
Jackson Creek Investment Advisors's Ironwood Pharmaceuticals position peaked at $1.31M in Q3 2021.
221 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2022.

Based on Jackson Creek Investment Advisors's 13F filing for Q1 2022, filed 3 May 2022.